1. Pan, Boyu, Cheng, Jun, Tan, Wei, Cheng, Xiaoyun, Deng, Youwen. 2024. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma. In Aging, 16, 8171-8197. doi:10.18632/aging.205810. https://pubmed.ncbi.nlm.nih.gov/38738999/
2. Chen, Jianan, Jiang, Youhai, Hou, Minghui, Wang, Hongyang, Fu, Jing. 2024. Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC. In Gut, 74, 128-140. doi:10.1136/gutjnl-2024-332902. https://pubmed.ncbi.nlm.nih.gov/39349007/
3. Xian, Huifang, Yang, Shuai, Jin, Shouheng, Zhang, Yuxia, Cui, Jun. 2019. LRRC59 modulates type I interferon signaling by restraining the SQSTM1/p62-mediated autophagic degradation of pattern recognition receptor DDX58/RIG-I. In Autophagy, 16, 408-418. doi:10.1080/15548627.2019.1615303. https://pubmed.ncbi.nlm.nih.gov/31068071/
4. Sun, Qijun, Jin, Lili, Dong, Shunli, Zhang, Ling. 2024. LRRC59 promotes the progression of oral squamous cell carcinoma by interacting with SRP pathway components and enhancing the secretion of CKAP4-containing exosomes. In Heliyon, 10, e28083. doi:10.1016/j.heliyon.2024.e28083. https://pubmed.ncbi.nlm.nih.gov/38533057/
5. Hannigan, Molly M, Hoffman, Alyson M, Thompson, J Will, Zheng, Tianli, Nicchitta, Christopher V. 2020. Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. In Molecular & cellular proteomics : MCP, 19, 1826-1849. doi:10.1074/mcp.RA120.002228. https://pubmed.ncbi.nlm.nih.gov/32788342/
智鼠故事 
